Inflammatory cells in diffuse large B cell lymphoma
R Tamma, G Ranieri, G Ingravallo, T Annese… - Journal of Clinical …, 2020 - mdpi.com
Diffuse large B cell lymphoma (DLBCL), known as the most common non-Hodgkin
lymphoma (NHL) subtype, is characterized by high clinical and biological heterogeneity. The …
lymphoma (NHL) subtype, is characterized by high clinical and biological heterogeneity. The …
Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective
M Bakhtiyaridovvombaygi, S Yazdanparast… - Biomarker …, 2024 - Springer
Abstract Non-Hodgkin lymphomas (NHLs) are heterogeneous and are among the most
common hematological malignancies worldwide. Despite the advances in the treatment of …
common hematological malignancies worldwide. Despite the advances in the treatment of …
[图书][B] Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance
B Bonavida, A Jewett - 2021 - books.google.com
Successes and Challenges of NK Immunotherapy: Increasing Anti-tumor Efficacy describes
the unique therapeutic applications of NK cells to fight cancers and eliminate the bulk and …
the unique therapeutic applications of NK cells to fight cancers and eliminate the bulk and …
Involvement of natural killer cells in the pathogenesis of lymphomas: Therapeutic implications
FR Kosasih, S Vivarelli, M Libra, B Bonavida - Successes and Challenges …, 2021 - Elsevier
Natural killer cells play a pivotal role in the control of various infectious diseases and
malignancies. Their functional activities are impaired in many cancers and, both directly and …
malignancies. Their functional activities are impaired in many cancers and, both directly and …